Innate Pharma SA
IPHADrugs in Pipeline
6
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
Get an email about IPHA's next catalysts
Track Innate Pharma (IPHA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming, 0 past
IPHA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: bmo
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Innate Pharma SA's drug pipeline?→
CatalystAlert tracks 6 drug candidates in Innate Pharma SA's (IPHA) pipeline across Phase 2. Its lead program is IPH2101 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Innate Pharma SA's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Innate Pharma SA (IPHA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track IPHA biotech catalysts?→
Add IPHA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Innate Pharma SA's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.